Joy Victory is Deputy Managing Editor of HealthNewsReview.org. She tweets at @thejoyvictory.
Like presumably many of my fellow Austin, Texas residents, I follow the Austin American-Statesman newspaper on Facebook because I want news–not sponsored advertorial content masquerading as journalism.
But that’s indeed what I got recently when I checked my phone and this popped up:
Because of the familiar blue logo and masthead symbol, I scanned it like I do any Facebook post from the Statesman–reading the headline and glancing at the photo to see if it’s relevant to me.
But, on second glance, I realized I had been duped–it was actually a “paid” post “sponsored” by Texas Oncology featuring a rather miraculous sounding survivor story. Following the link took me to a page that said “Texas Oncology Presents Men’s Health Awareness,” which included several promotional articles all nested under the Statesman’s masthead and navigation.
I’d like to think that if this was in print, it would clearly be a “special advertising supplement” tucked into the back of the paper, with all the other inserts. But when it’s online–and coming to me via Facebook–it’s much harder to tell what exactly is going on. The stories have bylines. They’re written in the third person, with quotes from patients, experts and loved ones. They read a whole heck of a lot like a typical news story. Yet, something’s a little off–things are all a little too cheery for the subject matter. (As we learn in one story, a brain cancer survivor’s wife says “I prayed to God to guide us to the right people. Get us to the right surgeon, the right oncologist, the right place, and He has.”)
This arrangement is clearly serving the cancer clinic–which gets potential new patients, since all the links from this site go directly to the clinic’s website–and the newspaper, which gets money.
But it’s not serving readers, because the medical information is not useful and instead may be harmful. The current featured story showcasing the atypical recovery of lawyer Phillip Durst is an example. We’re given the name of Durst’s doctor and details about his clinic (where the “staff is phenomenally knowledgeable, but also upbeat and friendly”). We’re not given many other facts readers need to know, such as:
All of these issues are addressed here: Six tips for writing accurately about cancer immunotherapy drugs
See our full coverage on this issue.
I can very easily see cancer patients getting their hopes raised by this article. It makes me cringe that they’re being given such lopsided information that paints the cancer center in only the most holy light possible.
“I understand that all news organizations need to find new ways to make money, but a page like this on a newspaper’s website is troubling,” said Andrew Seaman, ethics committee chairperson for the Society of Professional Journalists, in an email. “The page carries the newspaper’s flag and I can’t find anything that says these stories are not from the Statesman’s newsroom. At the very least, they need to do a better job at highlighting the difference between this content and the stories the paper actually produces.”
Seaman also suggested that on Facebook, there’s probably limited avenues to advertise the fact that the content is sponsored, but that the Statesman still needs to be more aggressive in pointing out the sponsorship. “For example, they might be able to put a ‘sponsored’ graphic somewhere on the picture,” he said.
The Statesman is far from alone. Last week the Columbia Journalism Review looked at the increasingly slippery path the New York Times is treading between news and advertising. We’ve also seen many recent similar examples of that we think, in the long run, will turn readers and viewers away and/or make them even more mistrustful of journalism. KARE-11, the NBC station in Minneapolis, for example, just ran a piece that was “co-authored” by someone on the public relations staff at the Mayo Clinic, which is one of the station’s major advertisers.
We think it goes without saying but we don’t mind repeating ourselves: When accepting money from a major medical organization that has enormous power over the health of many of your readers, it’s best to keep the separation of newsroom and advertising very, very clear. More: The trail of tainted funding: Conflicts of interest in healthcare, academics, public relations and journalism.
One also has to wonder how this also affects the reporters in the newsroom, who are undoubtedly aware of these special “branded content” arrangements and how they benefit their company’s bottom line. In the Statesman’s case, will their reporters still pursue important stories involving Texas Oncology knowing it may threaten the paper’s relationship with a major advertiser? We can only wonder.
Addendum: In addition to this issue, the Statesman recently apologized for and removed a real estate advertorial from their site after readers were outraged by the story’s claims about a historically black and Latino neighborhood.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like